- Fee assured
- Verified this account
This healthcare professional let us know that they are currently:
- Accepting new patients
- Available for:
- Phone consultations
Last updated: 29 Jun 2020
Lung cancer screening,
Early detection of lung cancer,
Investigation and treatment of respiratory symptoms, including cough, breathlessness.
Investigation and treatment of general medical conditions including assessments prior to surgery relating to respiratory disease.
Special clinical interests:
Respiratory infections (including TB, immunocompromised infections (HIV-related, haemato-oncology associated respiratory disease)
General medical conditions
Dr Sarah Doffman MB ChB FRCP was appointed as a consultant to Brighton and Sussex University Hospitals NHS Trust in 2008.
Having first qualified from Glasgow University Medical School in 1997, Sarah moved to London to complete her specialist training in respiratory and general medicine. She carried out research into the early diagnosis of invasive fungal pneumonia at St Bartholomew’s and Queen Mary, University of London and worked at the Royal Free Hospital, University College London Hospitals and St Bartholomew’s Hospitals developing expertise in lung cancer and respiratory infections.
Her specialist interests include lung infection and lung cancer, including screening for early detection of lung cancer.
She also has extensive experience in tuberculosis and respiratory disease in the immune-compromised host (HIV infection/post-chemotherapy or transplant) as well as general respiratory and medical conditions.
Following her consultant appointment to BSUH in 2008, Dr Doffman led services in TB and lung cancer in the Trust until 2014 when she was appointed as Clinical Director for the directorate of specialty medicine.
In late 2017, she became Chief of Medicine at Brighton and Sussex University Hospitals NHS Trust, overseeing medical services across both the Royal Sussex County and Princess Royal Hospital.
As well as leading the lung cancer service at BSUH NHS Trust between 2008 and 2018 through significant improvements in a number of key measures including survival rates, Sarah was also responsible for setting up the regional Endobronchial Ultrasound service for patients across Sussex in 2014. She was Chair of the Sussex Cancer Network Lung Tumour Group from 2010-2013. She has led two large projects funded by the Department of Health with National Cancer Survivorship Initiative into improving pathways of care and wellbeing in patients living with lung cancer.
Sarah was a member of the Specialist Advisory Group of the British Thoracic Society for Tuberculosis and the Multi-Drug Resistant Advisory Network from 2010-13, involved in national policy and education.
From 2010-12, Sarah led the Surrey and Sussex Specialist Respiratory Group Research Network (National Institute for Health Research) improving uptake to clinical trials in respiratory disease across the region. She was lead investigator of a number of trials at BSUH NHS Trust including a study of lung disease in HIV and a large multicentre trial in lung cancer diagnosis.
Areas of interest
Lung cancer screening; Early detection of lung cancer; Cough; investigation of breathlessness; investigation of abnormal chest X-Ray; unexplained respiratory symptoms; lung cancer; Respiratory infections; asthma; interstitial lung disease; chronic lung disease; COPD; Immunity and infection; bronchiectasis; endobronchial ultrasound; bronchoscopy;
Current NHS consultant posts held
Consultant in Respiratory and General Internal Medicine
Brighton and Sussex University Hospitals NHS Trust
Former Chief of Service for Medicine Division 2017-19
Former Clinical Director 2014-17
Member of the Tuberculosis Specialist Advisory Group of the British Thoracic Society 2010-13
Local lead of the Surrey and Sussex Comprehensive Local Research Network, National Institute for Health Research 2011-13
Fellow of the Royal College of Physicians, London
Lead investigator of a number of trials at BSUH NHS Trust including a study of lung disease in HIV and a large multicentre trial in lung cancer diagnosis 2009-current
I have a young son who takes up most of my spare time!
I enjoy theatre, concerts and running.
In the last 5 years I have co-authored 4 manuscripts in total and I have co-authored chapters for three textbooks on respiratory disease (Kumar and Clark, The ABC of HIV and AIDS, Manson's Tropical Diseases).
Peer reviewed publications:
1. Interstitial Lung Disease in HIV. Clin Chest Med. 2013 Jun;34(2):293-306. SR Doffman, RF Miller
2. Chronic Obstructive Pulmonary Disease in HIV: an emerging problem. Br J Hosp Med (Lond). 2014 Dec;75(12):678-84 AT Scourfield, SR Doffman, RF Miller
3. Impact of the revised (2008) EORTC/MSG definitions for invasive fungal disease on the rates of diagnosis of invasive aspergillosis. Med Mycol. 2012 Jul;50(5):538-42. Tsitsakis et al.
Courses offered to GPs
Lung cancer, Montefiore Hospital
- MB ChB University of Glasgow 1997
- FRCP Royal college of physicians, London 2012
Reference number 4436694
Professional bodies (positions held - last 3 yrs)
- BTS TB specialist advisory group British Thoracic Society 2013
Details of entry to specialist register
- Respiratory and General Internal Medicine, 2008
Affiliations / memberships
British Thoracic Society
Fellow of Royal College of Physicians
Medical Protection Society
British Medical Association
- Spire Montefiore Hospital, BN3 1RD
- 14:00 - 17:00
- 01273 828030
Post treatment communication
Following treatment of a Bupa member, I will communicate with GPs in line with Department of Health, GMC and appropriate professional bodies guidelines.
In the event of an urgent query following treatment, Bupa members should use the following contact details